Bitcoin & blockchain investment. Costliest startup failures. Financing to synthetic bio startups.
OMG, I make too much money
Hi there,
Everyone has quit a job cuz they were overpaid, right?
Block by block
From American Express to Deloitte to Goldman Sachs, major financial services firms have made investments in bitcoin and blockchain startups. To illustrate how activity has trended, we updated our timeline of each firm’s first investment into the space.
No stick Kalanick
So this weekend Susan J. Fowler, a former site reliability engineer at Uber, penned a post about why she left the company due to harassment. It is well worth a read (see The Blurb).
While tech Twitter and beyond are loudly calling for change at Uber and there have been renewed calls to #deleteuber, will this really impact Uber?
The company has been like teflon to-date with scandal after scandal getting the outrage machine going but then folks forget and going back to using the app.
The reasons for failure are varied, but a few common threads do emerge such as the inability to generate sustainable revenue, bad product-market fit, and losing to competitors.
__________
Join 200k+ marketers on eMarketer Daily for your down-low, daily briefing on the latest digital marketing, advertising, and media trends. Stay ahead of the curve with reputable, industry-standard research right in your inbox. Every morning. Rise and shine.
__________
Engineering life
We looked at funding trends to private synthetic biology companies, in addition to deal share distribution by stage. In 2016, equity funding to synthetic biology companies saw a 31% increase from $986M in 2015 to nearly $1.3B in 2016.